Episodic Migraine
Episodic migraine is a type of headache disorder characterized by recurrent attacks of moderate to severe headache, often accompanied by symptoms like nausea, vomiting, and sensitivity to light and sound.
Episodic Migraine: Atogepant for Kids and Teens
We are studying the safety and effectiveness of Atogepant tablets for children and teens aged 6 to 17 with episodic migraines. This trial compares the medication to a placebo to see if it helps reduce migraine symptoms.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 6 and 11 years old?
- Do you weigh between 44 lbs (20 kg) and 298 lbs (135 kg)?
- Have you had migraines for at least 6 months?
- Do you have 4 to 14 migraine days in the last 28 days?
- Do you have a history of migraine without brainstem aura or hemiplegic migraine?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Az St-Jan Brugge-Oostende A.V.
Paediatrics - paediatrics neurology
Sint-Andries, Belgium
Antwerp University Hospital
Pediatric Neurology
Wilrijk, Belgium
Aalborg University Hospital
Department of Pediatric and Adolescent
Aalborg, Denmark
Sponsor: Abbvie Deutschland GmbH & Co. KG
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.